Gabriella Gobbi Selected Research

N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamide

1/2018	Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.
10/2015	Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
2/2015	Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriella Gobbi Research Topics

Disease

12	Mood Disorders (Mood Disorder) 01/2019 - 01/2002
7	Mental Disorders (Mental Disorder) 12/2022 - 06/2003
7	Depressive Disorder (Melancholia) 01/2018 - 03/2008
6	Pain (Aches) 10/2020 - 01/2014
5	Neuralgia (Stump Neuralgia) 01/2019 - 02/2015
5	Psychotic Disorders (Schizoaffective Disorder) 11/2016 - 10/2006
4	Substance-Related Disorders (Drug Abuse) 01/2019 - 08/2014
4	Sleep Wake Disorders 01/2019 - 12/2011
3	Anhedonia 07/2020 - 03/2009
2	Bipolar Disorder (Manic Depressive Psychosis) 03/2022 - 08/2017
2	Alcoholism (Alcohol Abuse) 11/2021 - 01/2019
2	Major Depressive Disorder (Major Depressive Disorders) 09/2021 - 01/2021
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 01/2021
2	Autism Spectrum Disorder 01/2021 - 01/2021
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 10/2016
2	Anxiety Disorders (Anxiety Disorder) 01/2019 - 09/2012
2	Personality Disorders (Personality Disorder) 01/2019 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018 - 01/2014
2	Epilepsy (Aura) 01/2016 - 04/2006
1	Treatment-Resistant Depressive Disorder 01/2022
1	Inflammation (Inflammations) 09/2021
1	Social Phobia 01/2021
1	Hyperalgesia 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Cognitive Dysfunction 01/2018
1	Mania (Manias) 08/2017
1	Antisocial Personality Disorder (Antisocial Personality) 10/2016

Drug/Important Bio-Agent (IBA)

9	Antidepressive Agents (Antidepressants)IBA 03/2022 - 11/2008
9	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2005
7	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020 - 01/2002
7	MelatoninIBA 10/2020 - 06/2012
6	MT2 Melatonin ReceptorIBA 10/2020 - 01/2014
5	Hallucinogens (Psychedelics)IBA 12/2022 - 01/2018
5	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 11/2009
4	Quetiapine Fumarate (Seroquel)FDA Link 01/2018 - 01/2014
4	Valproic Acid (Depakote)FDA LinkGeneric 08/2017 - 04/2006
4	EndocannabinoidsIBA 09/2012 - 11/2008
3	N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamideIBA 01/2018 - 02/2015
3	Analgesics (Analgesic Drugs)IBA 01/2018 - 02/2015
3	Olanzapine (Zyprexa)FDA Link 01/2018 - 01/2014
3	Biological ProductsIBA 10/2016 - 06/2012
3	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 01/2002
2	Cocaine (Cocaine HCl)IBA 11/2021 - 01/2019
2	Tryptophan (L-Tryptophan)FDA Link 09/2021 - 03/2008
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 11/2009
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021 - 04/2006
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2021 - 01/2021
2	Ketamine FDA LinkGeneric 01/2021 - 01/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020 - 01/2019
2	Sucrose (Saccharose)IBA 07/2020 - 03/2009
2	LigandsIBA 01/2019 - 02/2015
2	Mirtazapine (Rexer)FDA LinkGeneric 01/2018 - 07/2009
2	Lysergic Acid Diethylamide (LSD)IBA 01/2018 - 11/2016
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2018 - 02/2015
2	Pharmaceutical PreparationsIBA 01/2018 - 10/2015
2	N- (2- ((3- methoxyphenyl)phenylamino)ethyl)acetamideIBA 01/2018 - 10/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 10/2006
2	acetamideIBA 10/2015 - 02/2015
2	Hypnotics and Sedatives (Sedatives)IBA 01/2014 - 12/2011
2	N-Methylaspartate (NMDA)IBA 11/2009 - 04/2006
1	A-factor (Streptomyces)IBA 11/2021
1	Biological FactorsIBA 09/2021
1	KynurenineIBA 09/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	6-hydroxynorketamineIBA 01/2021
1	Dronabinol (THC)FDA LinkGeneric 07/2020
1	MT1 Melatonin ReceptorIBA 01/2019
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	CannabidiolIBA 01/2019
1	CopperIBA 01/2019
1	CadmiumIBA 01/2019
1	Trace Elements (Biometals)IBA 01/2019
1	ZincIBA 01/2019
1	palmidrolIBA 01/2019
1	Doxepin (Mareen)FDA LinkGeneric 01/2018
1	BenzodiazepinesIBA 01/2018
1	suvorexantIBA 01/2018
1	Pregabalin (Lyrica)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	agomelatine (S20098)IBA 01/2018
1	Zolpidem (Ambien)FDA LinkGeneric 01/2018
1	Trazodone (Trittico)FDA LinkGeneric 01/2018
1	ramelteon (Rozerem)FDA Link 01/2018
1	zaleplon (Sonata)FDA LinkGeneric 01/2018
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Psilocybin (Psilocibin)IBA 01/2018
1	zopiclone (Zop)IBA 01/2018
1	LithiumIBA 08/2017
1	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2017
1	Aripiprazole (Abilify)FDA Link 08/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 08/2017
1	Lurasidone Hydrochloride FDA Link 01/2017
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 10/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Therapeutics 01/2014 - 01/2009
1	Analgesia 01/2019